Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bakelite Synthetics is a global leader in the development and manufacture of thermoset resins, molding compounds, and specialty chemicals. Headquartered in Columbus, Ohio, the company was established through the acquisition of Hexion's phenolic resins business by investment firms Black Diamond Capital Management and Investindustrial. Bakelite Synthetics serves diverse markets including automotive, aerospace, building and construction, and healthcare. In the life sciences and healthcare sectors, its materials are used for medical device components, diagnostic equipment, and laboratory supplies due to their chemical resistance and thermal stability. The company expanded its footprint significantly in 2022 through the acquisition of Georgia-Pacific Chemicals, enhancing its portfolio of wood adhesives and industrial resins. With a legacy dating back to the invention of the first synthetic plastic, the company continues to focus on sustainable chemical solutions and advanced material science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bakelite Synthetics.